Electrical Panels for Pharmaceutical & Life Sciences

Electrical Panels for Pharmaceutical & Life Sciences

Electrical panels for pharmaceutical and life sciences facilities are not generic industrial assemblies. They are engineered as part of a controlled manufacturing environment where product quality, patient safety, data integrity, uptime, and regulatory compliance all intersect. The scope typically extends beyond simple power distribution to include utility skids, HVAC and cleanroom support, process skids, CIP/SIP systems, packaging lines, laboratory automation, and critical monitoring functions. In practice, the panel is only “complete” when it is designed, built, tested, documented, installed, and validated in a way that supports GMP operations and audit readiness.

How the service is scoped

A pharmaceutical panel project usually begins with defining the intended use and compliance boundary. The engineering team must determine whether the panel is part of a machine, a process system, a building utility, or a standalone control assembly. That decision drives the applicable standards, risk assessment method, and validation depth. For EU projects, the scope often starts with CE conformity obligations under the relevant product legislation and machinery framework, then extends into site-specific GMP expectations and data integrity requirements.

Typical scoping inputs include:

• Process functional requirements and URS
• Electrical load list, short-circuit levels, and utility constraints
• Control philosophy, alarm strategy, and interlocks
• Environmental conditions: washdown, cleanroom, corrosive agents, temperature, vibration
• Cybersecurity and network segmentation requirements for connected panels
• Validation deliverables: FAT, SAT, IQ support, and documentation package

For machinery-related panels in the EU, the design team commonly aligns with EN ISO 12100 for risk assessment and EN 60204-1 for electrical equipment of machines. EN 60204-1 clauses 4 through 7 are especially relevant for general requirements, incoming supply, protection against electric shock, and control circuits. Where enclosure protection matters, IEC 60529 defines IP ratings, while IEC 61439 governs low-voltage switchgear and controlgear assemblies for power distribution panels.

How the panel is delivered

Delivery is usually organized as a controlled engineering package rather than a fabrication-only job. In pharmaceutical and life sciences work, the panel supplier is expected to produce traceable design outputs, not just hardware. Common deliverables include single-line diagrams, schematics, I/O lists, cable schedules, terminal plans, BOMs, PLC and HMI architecture, network diagrams, heat dissipation calculations, and test protocols. For regulated environments, document control is often as important as the hardware itself.

Mechanical and electrical design decisions are often driven by hygiene, maintainability, and uptime. Stainless steel enclosures may be preferred in washdown or corrosive areas. Separate compartments may be used for power, control, and communications to reduce noise and simplify maintenance. Terminal segregation and wire ducting are typically laid out to support troubleshooting and future expansion. If the panel interfaces with process instruments, intrinsic safety or separation requirements may apply depending on the hazardous area classification and system architecture.

Common engineering decisions include:

• Choosing IEC 61439 assemblies for distribution versus EN 60204-1 machine control panels
• Using remote I/O to reduce cabinet density and improve serviceability
• Separating clean power and noisy drives to protect instrumentation and communications
• Specifying redundant power supplies or UPS-backed control for critical utilities
• Designing for maintainability with front-access terminals and clear labeling

For networked systems, ISA-62443 principles are increasingly used to structure segmentation, access control, and secure remote support. While not a substitute for local regulatory compliance, ISA/IEC 62443-3-3 provides a useful basis for security requirements on control system components. In Europe, this also helps align engineering with NIS2-driven cybersecurity expectations for critical and important entities.

Validation and acceptance

Validation in this sector is about proving the panel performs as intended under defined operating conditions and that the evidence is auditable. Factory Acceptance Testing (FAT) is usually the first formal checkpoint. Site Acceptance Testing (SAT) confirms installation and integration. In GMP environments, these activities may support Installation Qualification (IQ) and Operational Qualification (OQ), depending on the validation strategy.

A good FAT normally checks wiring correctness, device tagging, I/O simulation, interlock logic, alarm behavior, network communication, and safety functions. Electrical tests may include continuity, insulation resistance, dielectric withstand, and functional verification. IEC 61439 requires verification of design and routine performance characteristics; routine verification is particularly relevant to each completed assembly. For machine panels, EN 60204-1 clause 18 addresses verification, including continuity of protective bonding and functional tests.

Documentation should be complete enough to support audits and maintenance. That usually means as-built drawings, component certificates, software backup, parameter lists, test records, and a controlled change history. In regulated life sciences projects, the panel supplier may also be asked to support CSV or CSA activities where software and data integrity are in scope.

Key standards and how they influence design

Area	Typical standard	Design impact
Machine electrical equipment	EN 60204-1	Supply disconnects, protective bonding, emergency stop, control circuits, verification
LV assemblies	IEC 61439	Temperature rise, short-circuit withstand, clearances, routine verification
Risk assessment	EN ISO 12100	Hazard identification and risk reduction measures
Enclosure ingress protection	IEC 60529	IP rating selection for cleanroom, washdown, or dust exposure
Industrial cybersecurity	ISA/IEC 62443-3-3	Zone/conduit segmentation, authentication, access control, secure remote access
North American installations	NFPA 70, NFPA 79	Field wiring, machine grounding, control circuit practices, installation rules

Common engineering decisions in pharma and life sciences

One of the most important decisions is whether the panel should be optimized for cleanliness, uptime, or flexibility. Cleanroom-adjacent panels may require smooth external surfaces, minimized ledges, and IP-rated enclosures. Utility panels for chilled water, WFI support, or compressed air often prioritize redundancy and maintainability. Process panels for reactors, mixers, or filling lines may emphasize deterministic control and validation traceability. Packaging lines frequently demand high I/O density, fast changeovers, and integration with MES or serialization systems.

Another recurring decision is the level of segregation between safety, process, and information networks. In modern plants, the panel may host PLCs, safety relays or safety PLCs, remote I/O, managed switches, and edge devices. Good practice is to keep safety functions clearly separated and documented, with safety-related control parts designed and validated according to the chosen machine safety architecture. For many projects, the practical target is a panel that is easy to test, easy to clean, secure to connect, and simple to maintain without disrupting GMP operations.

In short, a pharmaceutical or life sciences electrical panel is not just a cabinet with components; it is a validated asset supporting regulated production. The best projects are scoped early, designed to the correct standard set, built with maintainability in mind, and verified with enough evidence to stand up to both engineering review and regulatory scrutiny. If you are planning a new system or upgrading an existing line, discuss your project with us via /contact.